Navjot Dhillon in New York, New York

Home New York New York

Navjot Dhillon has Nurse Practitioner as her primary medical specialty. Their primary office is: 305 E 86th St in New York, New York. There is an additional office location, for a total of two, for Navjot Dhillon that can be viewed further down.

They're a part of the: George Safran Md Pc medical group which has around 86 members. You can call their office at 866-389-2727 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2020 (around 4 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Navjot Dhillon Office Phone and Directions

Navjot Dhillon
George Safran Md Pc
305 E 86th St
New York, New York 10028
866-389-2727

Patient Ratings
Please rate your experience with Navjot Dhillon below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 866-389-2727

Enter a starting address:

Healthcare Info for Navjot Dhillon

Medical School: Sorry, her university is not listed
Graduation Year: 2020
The Primary Medical Specialty for Navjot Dhillon is listed as: Nurse Practitioner
Approximate Years of Experience: 4
PAC (PECOS ID)#: 7517336050
NPI #: 1033885371
NPI Created On: 08/17/2021
NPI Last Updated Listed as: 07/13/2023
Primary Taxonomy Code: 363LF0000X
License Number:
348113
Listed Gender: Female

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 836071909

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Virology & Specialty Care

Name of Drug #1: Xofluza

Open Associated Drug #1: 50242-828-02